⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Official Title: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 Vaccine When Administered According to Alternative 2-dose Schedules in 9 - 14 Year Old Females

Study ID: NCT01381575

Study Description

Brief Summary: This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,12 months) in healthy 9-14 year old females as compared to the standard 3-dose schedule (0,1,6 months) in 15-25 year old females.

Detailed Description:

Eligibility

Minimum Age: 9 Years

Eligible Ages: CHILD, ADULT

Sex: FEMALE

Healthy Volunteers: Yes

Locations

GSK Investigational Site, Coquitlam, British Columbia, Canada

GSK Investigational Site, Halifax, Nova Scotia, Canada

GSK Investigational Site, Sudbury, Ontario, Canada

GSK Investigational Site, Toronto, Ontario, Canada

GSK Investigational Site, Woodstock, Ontario, Canada

GSK Investigational Site, Sherbrooke, Quebec, Canada

GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany

GSK Investigational Site, Kehl, Baden-Wuerttemberg, Germany

GSK Investigational Site, Schoenau Am Koenigssee, Bayern, Germany

GSK Investigational Site, Wuerzburg, Bayern, Germany

GSK Investigational Site, Hannover, Niedersachsen, Germany

GSK Investigational Site, Hannover, Niedersachsen, Germany

GSK Investigational Site, Wolfenbuettel, Niedersachsen, Germany

GSK Investigational Site, Wolfsburg, Niedersachsen, Germany

GSK Investigational Site, Kleve-Materborn, Nordrhein-Westfalen, Germany

GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany

GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany

GSK Investigational Site, Trier, Rheinland-Pfalz, Germany

GSK Investigational Site, Flensburg, Schleswig-Holstein, Germany

GSK Investigational Site, Weimar, Thueringen, Germany

GSK Investigational Site, Berlin, , Germany

GSK Investigational Site, Hamburg, , Germany

GSK Investigational Site, Genova, Liguria, Italy

GSK Investigational Site, Milano, Lombardia, Italy

GSK Investigational Site, Cuneo, Piemonte, Italy

GSK Investigational Site, Cagliari, Sardegna, Italy

GSK Investigational Site, Ragusa, Sicilia, Italy

GSK Investigational Site, Padova, Veneto, Italy

GSK Investigational Site, Taipei, , Taiwan

GSK Investigational Site, Taipei, , Taiwan

GSK Investigational Site, Taoyuan, , Taiwan

GSK Investigational Site, Bangkok, , Thailand

GSK Investigational Site, Chiangmai, , Thailand

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: